ADAP Crisis Task Force Announces Agreement with ViiV Healthcare for Tivicay®

FOR IMMEDIATE RELEASE
Contact: Meico Whitlock
202-434-8090

ADAP Crisis Task Force Announces Agreement with ViiV Healthcare for TivicayAugust 26, 2013, Washington, DC – The ADAP Crisis Task Force (ACTF) has reached a new pricing agreement with ViiV Healthcare for AIDS Drug Assistance Programs (ADAPs) for Tivicay® (dolutegravir) for the treatment of HIV-1 infected individuals. The agreed-upon ADAP direct purchase price for Tivicay®, negotiated between the ACTF and ViiV, is substantially lower than the wholesale acquisition cost (WAC), reflecting voluntary discounts that are also significantly below the mandated 340B pricing of the medication.

Continue reading

Affordable Care Act News: Navigator Final Rule Released

By Marilyn Tavenner

Cross-posted from AIDS.gov

Marilyn TavennerOn July 15, 2013, the Centers for Medicare & Medicaid Services (CMS) took the next step in moving toward implementation of the Health Insurance Marketplaces by finalizing a proposed rule outlining the standards for Navigators, the in-person assisters in Federally-facilitated and State Partnership Marketplaces. The rule identifies training, conflict of interest standards, and standards for serving people with limited English proficiency and people with disabilities. (Read more about the Marketplaces.)

Millions of Americans will be eligible for new coverage opportunities through the Marketplaces beginning January 2014. Navigators will be available to provide un-biased assistance to consumers about health insurance, the new Health Insurance Marketplaces, qualified health plans, and public programs including Medicaid and the Children’s Health Insurance Program (CHIP) as well as assist consumers in enrolling in coverage available through the Health Insurance Marketplaces. Continue reading

ADAP Crisis Task Force Announces Agreement with Industry Partners

FOR IMMEDIATE RELEASE
Contact: Murray Penner
202-434-8090
mpenner@NASTAD.org

ADAP Crisis Task ForceJuly 29, 2013, Washington, DC – As part of ongoing efforts by the ADAP Crisis Task Force (Task Force) and the pharmaceutical industry to address the continued need for access to HIV antiretroviral medicines through AIDS Drug Assistance Programs (ADAPs), the Task Force announced today that it has reached agreement with AbbVie, Gilead Sciences, Merck, and ViiV Healthcare to extend the voluntary discounts/rebates and price freezes available to all state ADAPs through December 31, 2014.

Continue reading

The Affordable Care Act (ACA): Preparing HIV and Viral Hepatitis Programs for Implementation

By Meico Whitlock, Senior Manager, Communications, NASTAD

In May at our 22nd Annual Meeting of state health department HIV and hepatitis program leaders in Washington, D.C., we had an opportunity to hear from federal and state leaders about Affordable Care Act (ACA) Implementation and its impact on HIV/AIDS and viral hepatitis program providers. Below is an interview with Amy Killelea, Senior Manager, Health Care Access at NASTAD and Maria Courogen, Director of Infectious Disease and Reproductive Health at the Washington State Department of Health who shared their highlights of the discussion. Continue reading

The HIV Care Continuum Initiative: The Next Step of the National HIV/AIDS Strategy

By Kathleen Sebelius, Secretary of Health and Human Services and Valerie Jarrett, Senior Advisor to the President

Cross-posted from AIDS.gov

Secretary Sebelius and Valerie Jarrett

Three years ago, President Obama announced an historic comprehensive plan to help turn the tide on HIV/AIDS in the United States: the National HIV/AIDS Strategy. The Strategy has given a new sense of direction, and purpose in our fight against HIV and AIDS.

Since the Strategy’s release, scientific developments have advanced our understanding of how to best fight HIV. We now understand that to prevent long-term complications of HIV, treatment is recommended for all adults and adolescents living with HIV in the United States. Continue reading